🎉 Huge congratulations to our resident company, HEPHAISTOS-Pharma, for winning their track at the Hello Tomorrow Global Challenge! 🎉 Out of 40,000 applications, only 10 track winners emerged—and HEPHAISTOS-Pharma proudly took the top spot in Medical Biotech & Pharmaceuticals. This recognition highlights the groundbreaking work behind ONCO-Boost, their novel TLR4 immunotherapy, and the immense potential of their next-generation cancer treatments. 👏 Bravo to Martine Caroff, Charles Dumontet, CEO Frédéric CAROFF, and the entire team for this well-deserved achievement. Your journey from scientific innovation to clinical impact continues to inspire! #DeepTech #Immunotherapy #BiotechInnovation #HelloTomorrow
𝐇𝐄𝐏𝐇𝐀𝐈𝐒𝐓𝐎𝐒-𝐏𝐡𝐚𝐫𝐦𝐚 𝐰𝐢𝐧𝐬 𝐢𝐭𝐬 𝐭𝐫𝐚𝐜𝐤 𝐚𝐭 𝐭𝐡𝐞 𝐇𝐞𝐥𝐥𝐨 𝐓𝐨𝐦𝐨𝐫𝐫𝐨𝐰 𝐆𝐥𝐨𝐛𝐚𝐥 𝐂𝐡𝐚𝐥𝐥𝐞𝐧𝐠𝐞! 40,000 applications. 80 finalists. 10 track winners. And HEPHAISTOS-Pharma, one of our portfolio companies, is among them, securing the top spot in Medical Biotech & Pharmaceuticals. The Hello Tomorrow Global Challenge is a leading competition for deep-tech startups transforming industries with breakthrough science. Winning a track is not just an achievement, it’s validation of the scientific and commercial potential behind a truly disruptive innovation. 𝐁𝐮𝐭 𝐇𝐄𝐏𝐇𝐀𝐈𝐒𝐓𝐎𝐒-𝐏𝐡𝐚𝐫𝐦𝐚’𝐬 𝐣𝐨𝐮𝐫𝐧𝐞𝐲 𝐝𝐢𝐝𝐧’𝐭 𝐬𝐭𝐚𝐫𝐭 𝐡𝐞𝐫𝐞: 🔹Developed ONCO-Boost, a novel TLR4 immunotherapy. 🔹Secured several million Euro to reach clinical stage. 🔹Recognized as a track winner at Hello Tomorrow. 𝐇𝐄𝐏𝐇𝐀𝐈𝐒𝐓𝐎𝐒-𝐏𝐡𝐚𝐫𝐦𝐚 HEPHAISTOS-Pharma is developing next-generation immunotherapies for cancer. Their lead drug candidate, ONCO-Boost, activates the patient’s innate immune response, training the body to recognize and attack non-responsive tumors and offering new hope where standard treatments fail. At xista science ventures, we invest in breakthrough science with real-world impact—backing visionary teams like HEPHAISTOS to bring pioneering research out of the lab and into the clinic. Big congratulations to founders Martine Caroff, Charles Dumontet, CEO Frederic CAROFF and the team 𝐖𝐡𝐚𝐭’𝐬 𝐧𝐞𝐱𝐭? 🔗 Discover our portfolio: xista.vc/portfolio 🔗 Learn more about HEPHAISTOS-Pharma: https://lnkd.in/e4ffNCAc #DeepTech #Biotech #Immunotherapy #VentureCapital #HelloTomorrow #LifeSciences #CancerTherapeutics
CEO at HEPHAISTOS-Pharma
5dThanks to the BioLabs France team